Last reviewed · How we verify
NCT05962580
Anterior Cruciate Ligament Reconstruction With and Without Lateral Extra-Articular Tenodesis Among High Demand Patients
NA trial testing Isolated anterior cruciate ligament reconstruction with lateral extra articular tenodesis in Anterior Cruciate Ligament Tear in 20 participants. Completed in 1 March 2023.
15 February 2022
Quick facts
| Lead sponsor | Ain Shams University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 15 February 2021 |
| Primary completion | 15 February 2022 |
| Estimated completion | 1 March 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Isolated anterior cruciate ligament reconstruction with lateral extra articular tenodesis
- Isolated anterior cruciate ligament reconstruction only
Conditions studied
- Anterior Cruciate Ligament Tear — all drugs for Anterior Cruciate Ligament Tear →
Sponsor
Ain Shams University
Who can join
Adults 18 to 40, any sex, with Anterior Cruciate Ligament Tear. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Anterior Cruciate Ligament Reconstruction with and without Lateral Extra-Articular Tenodesis between high demand patients
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05962580
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anterior Cruciate Ligament Tear
Currently open trials in the same condition.
- NCT05174611 — Vitamin D to Improve Quadricep Muscle Strength · Phase 2 · recruiting
- NCT06664047 — Over-the-Top vs. Anteromedial ACLR With Lateral Extraarticular Tenodesis · NA · recruiting
- NCT06511232 — Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction · Phase 4 · recruiting
- NCT06524349 — Utilization of a 3D Printed Customized Knee Extender and At-Home Rehabilitation Program on Patient Outcomes Following AC · NA · active not recruiting
- NCT06353503 — Bone Marrow Aspirate Concentrate for Anterior Cruciate Ligament Tear Treatment. · NA · recruiting
Other Ain Shams University trials
Trials by the same sponsor.
- NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
- NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
- NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
- NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
- NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05962580 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
- Last refreshed: 27 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05962580.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing